Core Laboratories N.V.

NYSE:CLB

Oil & Gas Equipment & Services

Energy
$8.45 +1.01%

+$0.12 today

Market cap
$387.21M
Beta
0.99
P/E (TTM)
18.3
EPS (TTM)
$0.63
Dividend yield
0.35%
52W Low $9.72High $20.36

Volume 0.52M

Average 0.49M

CLB Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Core Laboratories N.V.NYSE: CLB

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures growth accelerates

Q1 FY2026 capital expenditures of $4.89M (cash outflow) rose 36.7% year over year, ahead of the +19.3% change in trailing-twelve-month capital expenditures. Sequentially, it rose 35.6% from the prior quarter. Over 3 fiscal years it compounded at +12.6% a year.

Context

  • Capital expenditures amounted to 2.8% of revenue in FY2025, up 0.3 pp from a year earlier.
  • Capital expenditures grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +36.7% holds above the trailing-twelve-month pace of +19.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$4.89M+35.6% QoQ
Last fiscal yearDec 2025
-$14.59M+12.0% YoY
LTMMar 2026
-$16.16M+19.3% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+36.7%——
1 year+12.0%——
3-year CAGR+12.6%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(14.59M) USD
Year-over-year change
-12.0%

Capital Expenditures vs competitors

How CLB compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +19.3% is the 3rd highest of 10, against a peer median of -0.3%.
  • Capital expenditures amounts to 3.1% of revenue for CLB, versus a peer median of 30.7%.
CLB Competitors
Capital Expenditures for CLB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NBRNabors Industries Ltd.LTM Mar 2026$715.95M USD+14.0%+24.2%22.2%
HPKHighPeak Energy, Inc.LTM Mar 2026$425.7M USD-32.5%-26.4%55.2%
GRNTGranite Ridge Resources, IncLTM Mar 2026$387.71M USD+3.1%+21.3%85.1%
BORRBorr Drilling LimitedLTM Mar 2026$282.3M USD-32.1%+14.3%26.9%
PDSPrecision Drilling CorporationLTM Mar 2026CA$268.61M CAD+21.5%+12.6%14.3%
TXOTXO Partners, L.P.LTM Mar 2026$264.54M USD-0.3%+60.9%74.4%
SOCSable Offshore Corp.LTM Mar 2026$245.69M USD+81.2%—19330.6%
VTSVitesse Energy, Inc.LTM Mar 2026$84.49M USD-25.5%-95.4%30.7%
CAPLCrossAmerica Partners LPLTM Mar 2026$29.04M USD-4.2%+5.6%0.8%
CLBCore Laboratories N.V.LTM Mar 2026$16.16M USD+19.3%+12.6%3.1%
Peer median (excluding CLB) —-0.3%+13.5%30.7%

Competitors are the stored peer set for CLB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income20.22M19.66M37.03M32.15M31.8M
Depreciation & Amortization18.52M17.16M15.78M14.95M14.65M
Deferred Income Tax6.01M433K(10.81M)674K(4.74M)
Stock-Based Compensation19.09M7.76M13.97M3.76M7.14M
Change in Working Capital(24.25M)(25.02M)(28.77M)7.88M(5.57M)
Accounts Receivables(13.52M)(10.08M)(2.62M)(3.61M)(4.95M)
Inventory(4.55M)(14.86M)(12.98M)9.37M2.64M
Accounts Payables6.57M15.37M(12.88M)519K477K
Other Working Capital(12.75M)(15.46M)(300K)1.61M(3.73M)
Other Non-Cash Items(3.01M)4.97M(2.41M)(3.03M)(6.11M)
Operating Cash Flow36.58M24.96M24.79M56.39M37.18M
Capital Expenditures(13.54M)(10.22M)(10.58M)(13.03M)(14.59M)
Acquisitions (Net)873K240K00(1.24M)
Purchases of Investments13.54M0000
Sales of Investments726K0000
Other Investing Activities(11.82M)6.12M3.93M6.63M13.6M
Investing Cash Flow(10.22M)(3.86M)(6.65M)(6.39M)(2.23M)
Debt Repayment(71M)(15M)(9M)(38M)(16.71M)
Common Stock Issued60M0000
Common Stock Repurchased(8.26M)(3.9M)(2.2M)(5.31M)(12.43M)
Dividends Paid(1.83M)(1.85M)(1.87M)(1.88M)(1.87M)
Other Financing Activities(1.37M)(2.62M)(5.38M)(775K)(254K)
Financing Cash Flow(22.46M)(23.38M)(18.45M)(45.96M)(31.26M)
Effect of Forex Changes00000
Net Change in Cash3.9M(2.28M)(308K)4.04M3.69M
Free Cash Flow23.04M14.74M14.21M43.36M22.59M

Core Laboratories N.V.

NYSE:CLB

Intrinsic Alpha fair value

Locked

Current Price

$8.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.